Author: Di Micco, Pierpaolo; Di Micco, Gianluca; Russo, Vincenzo; Poggiano, Maria Rita; Salzano, Ciro; Bosevski, Marijan; Imparato, Michele; Fontanella, Luca; Fontanella, Andrea
Title: Blood Targets of Adjuvant Drugs Against COVID19 Cord-id: rqop3pm6 Document date: 2020_7_2
ID: rqop3pm6
Snippet: While waiting for the vaccine and/or the best treatment for COVID19, several drugs have been identified as potential adjuvant drugs to counteract the viral action. Several drugs, in fact, have been suggested for their ancillary antiviral role. Viral proteases and peptidases, may interact with well-known drugs such as anticoagulants, antihypertensives, antiserotoninergics and immunomodulants. We here report a basic list of these drugs that include bioflavonoids, heparinoids, ACE inhibitors, angio
Document: While waiting for the vaccine and/or the best treatment for COVID19, several drugs have been identified as potential adjuvant drugs to counteract the viral action. Several drugs, in fact, have been suggested for their ancillary antiviral role. Viral proteases and peptidases, may interact with well-known drugs such as anticoagulants, antihypertensives, antiserotoninergics and immunomodulants. We here report a basic list of these drugs that include bioflavonoids, heparinoids, ACE inhibitors, angiotensin receptor blockers, antiserotoninergics, and monoclonal antibodies against cytokines that may interact with the viral cycle.
Search related documents:
Co phrase search for related documents, hyperlinks ordered by date